COVID-19 spike proteins could evolve against immune responses
A new study suggests that COVID-19 spike proteins could evolve to disguise themselves from the human immune system.
European Commission outlines key actions to beat COVID-19
The European Commission has set out the key actions needed to step up the fight against the COVID-19 pandemic.
2,000 supply chain workers will be offered the COVID-19 vaccine
Up to 2,000 supply chain workers who are crucial to the delivery of the COVID-19 vaccine will be offered the vaccination themselves.
Over 4 million people receive first dose of COVID-19 vaccine
More than 4 million people have now received the first dose of the COVID-19 vaccine in the UK, according to the latest statistics.
Social care sector to receive further £120 million for additional care staff
The Government has allocated a further £120 million for the social care sector to help with staff shortages due to the pandemic.
Scientists use immune system to predict likelihood of long COVID
Cambridge researchers have published their findings on how the immune system could be an early clue for the later development of severe or long COVID.
Over 70s will begin to receive COVID-19 vaccine today
People aged 70 and over and those clinically extremely vulnerable will be invited to get their COVID-19 vaccinations from today.
NHS awarded £7.5 million to digitally schedule shifts
Government allocates £7.5 million to NHS hospitals, clinics and pharmacies across 38 trusts to implement digital shift planning.
DNA testing can rapidly identify pneumonia in COVID-19 patients
Researchers have developed a DNA test to rapidly identify pneumonia in COVID-19 patients, aiding faster treatment.
More than a third of people over 80 have received the COVID-19 vaccine
New data from Public Health England (PHE) shows that more than a third of people aged 80 and over have received the COVID-19 vaccine.
The vaccine isn’t a silver bullet for longstanding pressures in elderly care
Jitesh Patel, Project Director at Kajima Partnerships discusses why the vaccine is not a silver bullet for longstanding pressures in elderly care and how the sector must adapt post-pandemic.
New data shows that Sinovac COVID-19 vaccine is 50.4% effective
The São Paulo Government and Butantan Institute revealed that the Sinovac COVID-19 vaccine is 15.6% less effective than officials previously suggested.
People with COVID-19 immunity can still carry and transmit the virus
A new Public Health England (PHE) study has found that past coronavirus infection provides some immunity but people may still carry and transmit the virus.
How to prevent musculoskeletal pain when working from home
Rachel Brammer, Physiotherapist and Clinical Lead at Vitrue Health, explains how you can ensure your work from home set-up isn't harming your mental and physical health with problems such as musculoskeletal pain.
Will COVID-19 vaccination centres be open all night?
Today (13 January) Prime Minister Boris Johnson confirmed that COVID-19 vaccination centres would be running 24/7 "as soon as we can".
Indonesia gives emergency approval to Sinovac COVID-19 vaccine
The country has become the first in the world to approve the Sinovac COVID-19 vaccine, outside of China itself.
Over 2.2 million people receive first round of the COVID-19 vaccine
In the UK, over 2.2 million people have received the first round of the COVID-19 vaccine between 8th and 10th December, according to the latest figures.
Community initiative delivers 14,000 COVID-19 tests to Latinx workers
Unidos En Salud organisers have now provided COVID-19 testing to 14,000 people, targeting Latinx workers - one of the most hard-hit communities in San Francisco.
Government plans to vaccinate tens of millions of people by spring
The government has published its UK COVID-19 vaccines delivery plan which aims vaccinate tens of millions of people against COVID-19 by spring.
76% of COVID-19 patients still have one symptom, after six months
While long COVID is slowly becoming more understood, ordinary COVID-19 patients are experiencing lasting effects - scientists discovered that 76% of people have atleast one recurring symptom, six months after the original illness.
